_version_ 1784842102121693184
author Martino, Michael R.
Gutiérrez-Aguilar, Manuel
Yiew, Nicole K.H.
Lutkewitte, Andrew J.
Singer, Jason M.
McCommis, Kyle S.
Ferguson, Daniel
Liss, Kim H.H.
Yoshino, Jun
Renkemeyer, M. Katie
Smith, Gordon I.
Cho, Kevin
Fletcher, Justin A.
Klein, Samuel
Patti, Gary J.
Burgess, Shawn C.
Finck, Brian N.
author_facet Martino, Michael R.
Gutiérrez-Aguilar, Manuel
Yiew, Nicole K.H.
Lutkewitte, Andrew J.
Singer, Jason M.
McCommis, Kyle S.
Ferguson, Daniel
Liss, Kim H.H.
Yoshino, Jun
Renkemeyer, M. Katie
Smith, Gordon I.
Cho, Kevin
Fletcher, Justin A.
Klein, Samuel
Patti, Gary J.
Burgess, Shawn C.
Finck, Brian N.
author_sort Martino, Michael R.
collection PubMed
description
format Online
Article
Text
id pubmed-9713851
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-97138512022-12-01 Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids Martino, Michael R. Gutiérrez-Aguilar, Manuel Yiew, Nicole K.H. Lutkewitte, Andrew J. Singer, Jason M. McCommis, Kyle S. Ferguson, Daniel Liss, Kim H.H. Yoshino, Jun Renkemeyer, M. Katie Smith, Gordon I. Cho, Kevin Fletcher, Justin A. Klein, Samuel Patti, Gary J. Burgess, Shawn C. Finck, Brian N. Cell Rep Article 2022-11-15 /pmc/articles/PMC9713851/ /pubmed/36384117 http://dx.doi.org/10.1016/j.celrep.2022.111633 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Martino, Michael R.
Gutiérrez-Aguilar, Manuel
Yiew, Nicole K.H.
Lutkewitte, Andrew J.
Singer, Jason M.
McCommis, Kyle S.
Ferguson, Daniel
Liss, Kim H.H.
Yoshino, Jun
Renkemeyer, M. Katie
Smith, Gordon I.
Cho, Kevin
Fletcher, Justin A.
Klein, Samuel
Patti, Gary J.
Burgess, Shawn C.
Finck, Brian N.
Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
title Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
title_full Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
title_fullStr Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
title_full_unstemmed Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
title_short Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
title_sort silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713851/
https://www.ncbi.nlm.nih.gov/pubmed/36384117
http://dx.doi.org/10.1016/j.celrep.2022.111633
work_keys_str_mv AT martinomichaelr silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT gutierrezaguilarmanuel silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT yiewnicolekh silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT lutkewitteandrewj silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT singerjasonm silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT mccommiskyles silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT fergusondaniel silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT lisskimhh silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT yoshinojun silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT renkemeyermkatie silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT smithgordoni silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT chokevin silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT fletcherjustina silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT kleinsamuel silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT pattigaryj silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT burgessshawnc silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids
AT finckbriann silencingalaninetransaminase2indiabeticliverattenuateshyperglycemiabyreducinggluconeogenesisfromaminoacids